DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

DaVita, Inc. (NYSE: DVA)

73.65 -0.18 (-0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DVA $73.65 -0.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.93
Previous Close $73.83
Daily Range $73.53 - $74.08
52-Week Range $52.75 - $74.84
Market Cap $15.8B
P/E Ratio 23.36
Dividend (Yield) $0.00 (0.0%)
Volume 572,793
Average Daily Volume 898,438
Current FY EPS $3.61

Sector

Healthcare

Industry

Healthcare Information Services

DaVita, Inc. (DVA) Description

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease. Website: http://www.davita.com/

News & Commentary Rss Feed

Why Cliffs Natural Resources Inc., Monster Beverage Corporation, and DaVita HealthCare Partners Inc.

Shareholder drama, executive shakeups, and analyst downgrades made these three names the worst performers in the stock market today

DaVita Seems to be a High-Growth Company

Analysts' Actions: Davita, Gilead, G&K Services, Omnivision, More

UPDATE: Deutsche Bank Downgrades DaVita HealthCare Partners

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

Insider Trading Alert - MPWR, DVA And TWO Traded By Insiders

3 Health Services Stocks Driving The Industry Higher

Mario Gabelli Reports his Top Increases of the Second Quarter

Mario Gabelli Reports his Top Increase of the Second Quarter

Update: DaVita Is Still Undervalued, Despite Headwinds

DaVita Healthcare Beats on Q2 Earnings, Revises Guidance - Analyst Blog

See More DVA News...

DVA's Top Competitors

DVA $73.65 (-0.24%)
Current stock: DVA
UNH $83.78 (0.01%)
Current stock: UNH
WLP $112.87 (-0.22%)
Current stock: WLP
$0.00 (0.00%)
Current stock: